Find a lawyer
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod.
Our differentiated approach
Deep sector expertise
Our deep sector-specific expertise means that we can help private capital clients assess and allocate risks affecting complex assets and revenue streams across the range of investment strategies
Range of execution capability
Our multi-disciplinary transaction teams enable us to serve clients at every stage of the private capital investment life cycle, from fund formation and capital deployment through asset management to exits
Market reach
We approach private capital as our target clients do, as a single integrated team, combining best-in-class global market experience, broad regional capability and deep local knowledge
Our breadth of expertise enables us to serve private capital clients at every stage of the investment life cycle.
Experience
Ariosa Diagnostics
in defending multiple patent infringement suits in Europe and in Australia on behalf of Ariosa Diagnostics over a period of several years, in relation to the Harmony® non-invasive prenatal test.
AbbVie
in defending a UK patent infringement in relation to the autoinjector used to deliver AbbVie's Humira, the biggest-selling pharmaceutical product globally at the time.
Becton Dickinson & Company
in defending a claim for patent infringement by B. Braun against Becton Dickinson in the Federal Court of Australia. Successfully invalidated three of Braun's patents relating to IV catheters
Multinational diagnostics company
on various EU and UK regulatory queries, including on the medical devices regulations and Brexit-related regulatory challenges
Foundation Medicine
in defending patent infringement proceedings brought in German and advised on broader European patent litigation strategy in relation to Foundation Medicine in relation to FoundationOne® Liquid - a liquid biopsy and companion diagnostic product.
Sanofi
in successfully defending revocation proceedings and provided strategic advice in relation to the injection pen used to deliver Sanofi's Lantus and Solostar – Lantus at the time was Sanofi's leading diabetes medicine.
Awards and recognition
Commercial Property: Investment, Development & Corporate Occupiers - Tier 1
Legal 500 UK 2024
"They are responsive, client focused and have in depth commercial understanding. They provide pragmatic and forward thinking solutions."
Legal 500 UK 2024
Banking & Finance: Acquisition Finance – Band 1
Chambers APAC 2023
Power – Band 1
Chambers UK 2024
"A top tier real estate practice, who bring excellence to everything they do. The are capable of handling any top-Drawer real estate transaction."
Legal 500 UK 2024
Banking & Finance: Asset Finance & Lease – Band 1
Chambers APAC 2023